Morning NewsDocmorris Sees Break-even within Reach in 2024
Docmorris narrowed its operating loss last year. At the bottom line, the company made a profit thanks to the sale of its Swiss business. In the current year, Docmorris wants to grow, also thanks to the e-prescription in Germany, and is forecasting an operating break-even. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) from continuing operations amounted to minus CHF 35 million in 2023, as most recently expected by the company, following a loss of CHF 85.5 million in the previous year.